1. Home
  2. PERI vs STRO Comparison

PERI vs STRO Comparison

Compare PERI & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perion Network Ltd.

PERI

Perion Network Ltd.

SELL

Current Price

$8.72

Market Cap

346.5M

Sector

Technology

ML Signal

SELL

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$10.96

Market Cap

332.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PERI
STRO
Founded
1999
2003
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
346.5M
332.8M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
PERI
STRO
Price
$8.72
$10.96
Analyst Decision
Buy
Strong Buy
Analyst Count
6
14
Target Price
$13.00
★ $47.23
AVG Volume (30 Days)
237.2K
★ 281.2K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $38,419,000.00
Revenue This Year
$5.75
N/A
Revenue Next Year
$10.33
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$7.63
$0.72
52 Week High
$11.27
$43.85

Technical Indicators

Market Signals
Indicator
PERI
STRO
Relative Strength Index (RSI) 48.09 25.43
Support Level $8.28 $10.52
Resistance Level $9.70 $16.99
Average True Range (ATR) 0.24 1.23
MACD 0.06 -0.25
Stochastic Oscillator 51.91 12.94

Price Performance

Historical Comparison
PERI
STRO

About PERI Perion Network Ltd.

Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: